Updated Dec 27, 2023, 7:34 am EST / Original Dec 27, 2023, 4:26 am EST Stock futures traded slightly lower Wednesday after the S&P 500 finished higher Tuesday and…
Read more Intel, Tesla, Apple, Iovance, NetEase, Coherus BioSciences, and More Stock Market MoversBristol Myers Squibb will acquire radiopharmaceutical therapeutics company RayzeBio for $62.50 a share in cash. Continue reading this article with a Barron’s subscription. View Options Source link
Read more Bristol Myers to Acquire RayzeBio in Deal Valued at $4.1 BillionTwo weeks ago, bluebird bio secured Food and Drug Administration approval for its gene therapy for sickle cell disease, a significant milestone for the roughly 100,000 people in…
Read more Bluebird Bio Stock Is in Free FallDec 19, 2023, 4:31 am EST Stock futures traded flat Tuesday, a day after the S&P 500 finished up 0.5% and moved closer to its all-time. The broad…
Read more Alphabet, Heico, Bluebird Bio, Plug Power, UBS, FedEx, and More Stock Market Movers7% Dividend Yields or Higher: The S&P 500’s 6 Best Payouts Source link
Read more 7% Dividend Yields or Higher: The S&P 500’s 6 Best PayoutsThis copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com. https://www.barrons.com/articles/stock-market-movers-8c0c7b23 Updated Sept. 19, 2023…
Read more NIO, Moderna, Block, U.S. Steel, and More Stock Market MoversJohnson & Johnson on Wednesday issued new financial guidance after spinning out the consumer-health company Kenvue While its earnings and sales projections were lowered on an absolute basis,…
Read more Johnson & Johnson Maintains Dividend After Kenvue SpinoutJohnson and Johnson $40 billion exchange offer for shares in Kenvue is likely to generate strong interest from the healthcare company’s shareholders, resulting in participants being able to…
Read more J&J’s Kenvue Deal Could Be Too Popular. What Happens if It Is.Pfizer Stock Gains After Earnings Beat. Revenue and Outlook Aren’t So Good. Source link
Read more Pfizer Earnings Beat. Guidance Disappoints.We’ve detected you are on Internet Explorer. For the best Barrons.com experience, please update to a modern browser. We’ve detected you are on Internet Explorer. For the best…
Read more Chegg, Arista, Uber, Pfizer, DuPont, and More Stock Market MoversThis copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com. https://www.barrons.com/articles/stock-market-movers-88cae2de Updated April 5, 2023…
Read more J&J, C3.ai, Albemarle, Walmart, and More Stock Market MoversNearly two years after biotechnology stocks began to tumble, executives at small and midsize companies in the space are finally accepting that share prices aren’t bouncing back anytime…
Read more Tanking Biotech Stocks Will Mean a Big Year for Deals. Who Could Benefit.Moderna stock shot up after Merck said it is exercising an option to work on a personalized cancer vaccine with the Covid-19 vaccine maker. Merck (ticker: MRK) will…
Read more Moderna Stock Takes Off on Cancer Vaccine News
